SANDOZ APREMILAST

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 36aeb0846229beb6
Drug Approval Canada Name: SANDOZ APREMILAST
Product Name: SANDOZ APREMILAST
Status: Marketed
Status Date: 2022-11-18
Original Market Date: 2022-11-18
Din: 02529084
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:24.24.92
Atc Original: L04AA32 APREMILAST
Atc Name: l 04 aa 32
Aig Number: 0156231002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

APREMILAST

30 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

36aeb0846229beb6

Type

Standard